Introduction: Thirty Years of Cardiomyopathy.- I Hypertrophic Cardiomyopathy.- Evolution of Left Ventricular Hypertrophy in Patients with Hypertrophic Cardiomyopathy.- The Natural History and Clinical Course of Hypertrophic Cardiomyopathy.- Left Ventricular Systolic and Diastolic Function in Hypertrophic Cardiomyopathy.- Radionuclide Assessment of Diastolic Function in Hypertrophic Cardiomyopathy: Relation to Symptoms and Prognosis.- Ischemia, Coronary Blood Flow, and Coronary Reserve in Hypertrophic Cardiomyopathy.- Left Ventricular Diastolic Function and Myocardial Ischemia in Hypertrophic Cardiomyopathy: Assessment by Radionuclide Methods.- Sudden Death in Hypertrophic Cardiomyopathy: Identification and Management of High Risk Patients.- Electrophysiologic Studies in Patients with Hypertrophic Cardiomyopathy: Safety and Relation of Results to Clinical Findings.- Cerebral Embolic Risk in Hypertrophic Cardiomyopathy.- Cytogenetic Studies in Familial Hypertrophic Cardiomyopathy: Identification of a Fragile Site on Human Chromosome 16.- Medical Treatment of Hypertrophic Cardiomyopathy.- Surgical Results in Patients with Hypertrophic Obstructive Cardiomyopathy.- Utility of Intraoperative Echocardiography in Planning Surgical Strategy in Obstructive Hypertrophic Cardiomyopathy.- Rational Choice of Medical and/or Surgical Therapy in Hypertrophic Cardiomyopathy.- Changes in Left Ventricular Hemodynamics of Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients Treated with VAT Sequential Pacing.- Future Trends in Research in Hypertrophic Cardiomyopathy.- II Dilated Cardiomyopathy.- 1 Pathogenesis of Dilated Cardiomyopathy.- Experimental Viral Myocarditis: Immunopathogenetic Aspects.- Dichotomous Effects of Cyclophosphamide in Murine Coxsackievirus B3-Induced Myocarditis.- Enterovirus RNA Sequences in Hearts with Dilated Cardiomyopathy: A Pathogenetic Link Between Virus Infection and Dilated Cardiomyopathy.- HLA Haplotype in Idiopathic Dilated Cardiomyopathy: GeneticallylCs